Health Care & Life Sciences » Pharmaceuticals | Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2013
2014
2016
2017
2018
Sales/Revenue
1,231
1,690
3,084
3,902
5,398
Cost of Goods Sold (COGS) incl. D&A
980
1,273
2,181
2,525
2,963
Gross Income
251
417
904
1,378
2,435
SG&A Expense
58
97
199
339
678
EBIT
190
316
699
1,130
1,758
Non Operating Income/Expense
13
24
59
34
127
Interest Expense
2
7
4
6
1
Pretax Income
221
357
800
1,218
1,884
Income Tax
81
98
190
257
437
Consolidated Net Income
140
259
610
960
1,446
Net Income
140
258
610
962
1,448
Net Income After Extraordinaries
140
258
610
962
1,448
Net Income Available to Common
140
258
610
962
1,448
EPS (Basic)
1.85
3.42
8.07
12.73
19.26
Basic Shares Outstanding
76
76
76
76
-
EPS (Diluted)
1.85
3.42
8.07
12.72
-
Diluted Shares Outstanding
76
76
76
76
-
EBITDA
205
351
799
1,263
1,948
Other Operating Expense
3
3
5
92
-
Non-Operating Interest Income
20
24
47
59
-
Minority Interest Expense
-
-
1
1
2

About Caplin Point Laboratories

View Profile
Address
Narbavi
Chennai Tamil Nadu 600017
India
Employees -
Website http://www.caplinpoint.net
Updated 09/14/2018
Caplin Point Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It offers antibiotics, non-steroidal anti-inflammatory drugs (NSAIDS), ophthalmics, pain management, and anti-ulcer products. The company was founded on April 16, 1990 and is headquartered in Chennai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.